Flexion Therapeutics Names Melissa Layman Chief Commercial Officer
Flexion Therapeutics, Inc. (FLXN)
Last flexion therapeutics, inc. earnings: 11/7 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.flexiontherapeutics.com
Company Research
Source: GlobeNewswire
BURLINGTON, Mass., March 11, 2020 (GLOBE NEWSWIRE) -- Flexion Therapeutics, Inc. (Nasdaq:FLXN) today announced that Melissa Layman has been named Chief Commercial Officer (CCO). Ms. Layman joins Flexion with more than 25 years of commercial experience within the life science industry. Over the course of her career she has held positions of increasing responsibility across all areas of commercial operations including sales, marketing, market access and analytics. Flexion Therapeutics Names Melissa Layman Chief Commercial Officer “I am genuinely delighted to welcome Melissa to Flexion during one of the most exciting periods in Flexion’s history,” said Michael Clayman, M.D., President and Chief Executive Officer of Flexion. “She combines deep and broad commercial expertise with important leaders
Show less
Read more
Impact Snapshot
Event Time:
FLXN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
FLXN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
FLXN alerts
High impacting Flexion Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics